Ortivus
ISIN: SE0000188930 | Ticker: ORTI | LEI: 549300AVDV7UC14MTH79
Country: Sweden
With more than 30 years of experience in cardiology and medical technology, we are today one of the market leaders in e-health. We are still a tight and flexible organisation where each individual employee has a significant impact. It is also our employees’ knowledge and commitment that is creating value and success for our customers. Together we make a difference in people’s lives. For real.
Year founded1985
Served areaEurope
HeadquartersOrtivus AB Svärdvägen 19, 18233 Danderyd – Sweden
| Line item in (sek) | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|
| Assets | 66,550,000.00 | 72,459,000.00 | 89,750,000.00 |
| Noncurrent Assets | 10,266,000.00 | 17,087,000.00 | 23,500,000.00 |
| Property Plant And Equipment | 1,702,000.00 | 1,939,000.00 | 2,160,000.00 |
| Intangible Assets Other Than Goodwill | 7,263,000.00 | 11,635,000.00 | 15,047,000.00 |
| Other Noncurrent Financial Assets | 1,497,000.00 | 0.00 | N/A |
| Other Noncurrent Nonfinancial Assets | 1,301,000.00 | 3,513,000.00 | N/A |
| Current Assets | 56,284,000.00 | 55,372,000.00 | 66,250,000.00 |
| Inventories | 3,489,000.00 | 4,777,000.00 | 14,397,000.00 |
| Current Trade Receivables | N/A | 21,406,000.00 | 32,859,000.00 |
| Other Current Receivables | N/A | 849,000.00 | 1,945,000.00 |
| Cash and cash equivalents | 22,127,000.00 | 22,112,000.00 | 7,597,000.00 |
| Cash Equivalents | 22,127,000.00 | 22,112,000.00 | N/A |
| Equity And Liabilities | 66,550,000.00 | 72,459,000.00 | 89,750,000.00 |
| Equity | 19,678,000.00 | 29,444,000.00 | N/A |
| Issued Capital | 15,508,000.00 | 15,508,000.00 | 15,508,000.00 |
| Retained Earnings | -28,661,000.00 | -19,450,000.00 | -13,558,000.00 |
| Share Premium | 32,787,000.00 | 32,787,000.00 | N/A |
| Other Reserves | 44,000.00 | 599,000.00 | N/A |
| Additional Paidin Capital | N/A | 32,787,000.00 | 32,787,000.00 |
| Equity Attributable To Owners Of Parent | 19,678,000.00 | 29,444,000.00 | 35,435,000.00 |
| Liabilities | 46,872,000.00 | 43,015,000.00 | 54,315,000.00 |
| Noncurrent Liabilities | 140,000.00 | 12,090,000.00 | 11,073,000.00 |
| Noncurrent Payables | 140,000.00 | 2,041,000.00 | N/A |
| Noncurrent Contract Liabilities | N/A | 10,049,000.00 | 6,909,000.00 |
| Other Noncurrent Financial Liabilities | 0.00 | 10,049,000.00 | N/A |
| Current Liabilities | 46,732,000.00 | 30,925,000.00 | 43,242,000.00 |
| Trade And Other Current Payables | 3,760,000.00 | 2,860,000.00 | 16,303,000.00 |
| Current Accruals And Current Deferred Income Including Current Contract Liabilities | N/A | 16,175,000.00 | 18,069,000.00 |
| Current Contract Liabilities | N/A | 7,302,000.00 | 1,592,000.00 |
| Current Advances | 24,122,000.00 | 7,302,000.00 | N/A |
| Other Current Financial Liabilities | 868,000.00 | 1,269,000.00 | N/A |
| Other Current Liabilities | N/A | 3,319,000.00 | 5,304,000.00 |
| Line item in (sek) | 01.01.2020/ 01.01.2021 |
01.01.2021/ 01.01.2022 |
01.01.2022/ 01.01.2023 |
|---|---|---|---|
| Revenue | 107,582,000.00 | 94,272,000.00 | 104,509,000.00 |
| Other Income | 8,986,000.00 | 3,204,000.00 | 1,606,000.00 |
| Profit Loss From Operating Activities | 11,392,000.00 | 9,346,000.00 | 5,847,000.00 |
| Finance Income | 37,000.00 | 31,000.00 | 0.00 |
| Finance Costs | 97,000.00 | 166,000.00 | 34,000.00 |
| Insurance Finance Income Expenses From Insurance Contracts Issued Recognised In Profit Or Loss | -60,000.00 | -135,000.00 | N/A |
| Cumulative Gain Loss Previously Recognised In Other Comprehensive Income Arising From Reclassification Of Financial Assets Out Of Fair Value Through Other Comprehensive Income Into Fair Value Through Profit Or Loss Measurement Category | -409,000.00 | 555,000.00 | N/A |
| Profit Loss Before Tax | 11,332,000.00 | 9,211,000.00 | 5,813,000.00 |
| Income Tax Expense Continuing Operations | 0.00 | 0.00 | -79,000.00 |
| Profit (loss) | 11,332,000.00 | 9,211,000.00 | 5,892,000.00 |
| Profit Loss Attributable To Owners Of Parent | 11,332,000.00 | 9,211,000.00 | 5,892,000.00 |
| Line item in (sek) | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|
| Profit (loss) | 11,332,000.00 | 9,211,000.00 | 5,892,000.00 |
| Adjustments For Reconcile Profit Loss | N/A | 5,446,000.00 | 1,090,000.00 |
| Adjustments For Decrease Increase In Inventories | 525,000.00 | -1,273,000.00 | -9,620,000.00 |
| Adjustments For Decrease Increase In Other Operating Receivables | -16,592,000.00 | 1,630,000.00 | -15,774,000.00 |
| Adjustments For Increase Decrease In Trade Account Payable | 22,859,000.00 | -7,240,000.00 | N/A |
| Adjustments For Reconcile Profit Loss | N/A | 5,446,000.00 | 1,090,000.00 |
| Cash Flows From Used In Operations | 18,630,000.00 | 7,774,000.00 | -6,878,000.00 |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | 1,783,000.00 | 896,000.00 | 1,089,000.00 |
| Purchase Of Intangible Assets Classified As Investing Activities | 950,000.00 | 5,806,000.00 | 5,004,000.00 |
| Purchase Of Other Longterm Assets Classified As Investing Activities | N/A | 0.00 | 56,000.00 |
| Cash Flows From Used In Investing Activities | -2,733,000.00 | -6,702,000.00 | -6,149,000.00 |
| Repayments Of Borrowings Classified As Financing Activities | 1,309,000.00 | 0.00 | N/A |
| Payments Of Lease Liabilities Classified As Financing Activities | 863,000.00 | 1,240,000.00 | 1,490,000.00 |
| Cash Flows From Used In Financing Activities | -2,172,000.00 | -1,240,000.00 | -1,490,000.00 |
| Increase (decrease) in cash and cash equivalents before effect of exchange rate changes | 13,725,000.00 | -168,000.00 | -14,517,000.00 |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | -276,000.00 | 153,000.00 | 2,000.00 |
| Increase (decrease) in cash and cash equivalents after effect of exchange rate changes | 22,127,000.00 | 22,112,000.00 | N/A |
| Cash and cash equivalents | 22,127,000.00 | 22,112,000.00 | 7,597,000.00 |
Please note that some sums might not add up.
| Date | Trading entity / Person | Association | Trade type | Volume |
|---|---|---|---|---|
| 05.05.23 | Peter Edwall | Other | Buy | SEK 320,470.35 |
| 05.05.23 | Peter Edwall | Other | Buy | SEK 102,295.04 |
| 21.09.22 | Peter Edwall | Other | Sell | SEK 102,295.04 |
| 01.06.21 | Peter Edwall | Other | Buy | SEK 40,958.50 |
SE0000188930
LEI549300AVDV7UC14MTH79
SectorHealth Care Equipment & Services
IndustryHealth Care Equipment & Supplies
Sub-IndustryKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.